Dallas, TX - The CHECKMATE study, showing that using more than one marker of myocardial necrosis at the bedside can better predict risk of subsequent cardiac events, has been published in the April 10 ...
DUBLIN--(BUSINESS WIRE)--The "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback